MEDIROM Healthcare Technologies (NYSE:MRM) Trading Down 2.3% – Here’s Why

MEDIROM Healthcare Technologies Inc. (NYSE:MRMGet Free Report)’s stock price traded down 2.3% during trading on Thursday . The stock traded as low as $1.36 and last traded at $1.42. 6,232 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 702,966 shares. The stock had previously closed at $1.45.

MEDIROM Healthcare Technologies Price Performance

The company’s fifty day simple moving average is $1.20 and its 200 day simple moving average is $0.97.

Hedge Funds Weigh In On MEDIROM Healthcare Technologies

An institutional investor recently bought a new position in MEDIROM Healthcare Technologies stock. Heights Capital Management Inc. bought a new stake in MEDIROM Healthcare Technologies Inc. (NYSE:MRMFree Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 35,582 shares of the company’s stock, valued at approximately $37,000. Heights Capital Management Inc. owned 0.72% of MEDIROM Healthcare Technologies as of its most recent filing with the Securities and Exchange Commission (SEC).

About MEDIROM Healthcare Technologies

(Get Free Report)

MEDIROM Healthcare Technologies Inc provides holistic healthcare services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology.

Featured Articles

Receive News & Ratings for MEDIROM Healthcare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDIROM Healthcare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.